These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20683667)

  • 1. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
    Mevorach D
    Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
    Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M
    J Immunol; 2009 Dec; 183(12):8225-31. PubMed ID: 20007586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A; Pipi E; Soufleros K
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C; Wetterö J
    Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
    Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B
    J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
    Flierman R; Daha MR
    Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.